Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea
· Delayed Price · Currency is KRW 12,050
-240 (-1.95%)
At close: Apr 28, 2026
Biodyne Revenue
Biodyne had revenue of 859.47M KRW in the quarter ending September 30, 2025, a decrease of -43.44%. This brings the company's revenue in the last twelve months to 4.98B, up 8.97% year-over-year. In the year 2024, Biodyne had annual revenue of 5.27B with 28.93% growth.
Revenue (ttm)
4.98B
Revenue Growth
+8.97%
P/S Ratio
72.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
358.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.27B | 1.18B | 28.93% |
| Dec 31, 2023 | 4.09B | -8.12B | -66.51% |
| Dec 31, 2022 | 12.21B | 8.45B | 224.46% |
| Dec 31, 2021 | 3.76B | 92.26M | 2.51% |
| Dec 31, 2020 | 3.67B | -418.31M | -10.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RecensMedical | 8.83B |
| M.I.TECH Co.,Ltd | 67.15B |
| Synergy Innovation | 113.05B |
| BIOBIJOU | 28.49B |
| Celemics | 5.77B |
| Livsmed | 51.19B |
| Curiox Biosystems | 5.15B |
| Corentec | 100.43B |